EMA’s CHMP Backs Six New Products in January
The Evolving BTK Story in Multiple Sclerosis: Clinical Report
Diagonal Banks Another $125M for ‘Clustering’ Antibody Drugs
Pipeline Cuts for Sanofi; Breakthru Medicine Raises $60M
Sanofi’s Venglustat Succeeds in Phase 3 Gaucher Trial but Fails Separate Study in Fabry Disease
FDA Sets Feb. 1 Launch Date for PreCheck Pilot To Strengthen Domestic Supply Chain
Ocugen Shares Fall, Despite Positive Eye Disorder Trial
Amgen Adds AML Candidate in Deal for U.K.-based Dark Blue: Deals Report
‘Almost Like a Religion’: Pfizer CEO Slams RFK Jr.’s 'Anti-Science' Vaccine Policies
WEF Highlights 32 AI Case Studies with Real-World Business Impact
Proteasomes: A Novel Approach to Target the Immune System
JPM26 Recap, Novo’s Oral Wegovy Soars as Lilly’s Orforglipron Is Delayed, IPOs Return
TrumpRx Delayed Amid Potential Anti-Kickback Concerns
FDA Delays Decision for Lilly’s Obesity Pill Orforglipron, Other Priority Voucher Awardees: Report
BrightInsight Secures $13M Funding Round
Facing Talent Crunch, Radiopharma Field Casts a Wide Net
Call Goes Out for Type 1 Diabetes Screening in UK
Mixed Data Mars Sanofi's Venglustat Programme
5 Questions Facing Biopharma in 2026
ABB Showcases the Future of Lab Automation at SLAS 2026
Zip Launches Enterprise Transformation Office, Tapping Former Fortune 500 CPOs to Guide Procurement Leaders Through AI-Era Change
Enable Injections Scoops Up $30M
Lifordi Immunotherapeutics Inks New Funding
Evommune Soars as Dermatitis Treatment Rivals Dupixent in Mid-Stage Trial
The New Gold Rush in Brain Science
Ongoing Regulatory Uncertainty Means Innovation Is Now Higher Risk
Sanofi Moves Away From mRNA Flu Vaccine as CEO Projects Confidence
Boehringer Signs €1bn+ Deal for Simcere IBD Candidate
Sanofi Expects Vaccine Sales Growth to Dip Amid ‘Challenging Environment’
2025 Novel Large Molecule FDA Drug Approvals
Sanofi Adds HBV Vaccine, Shingles Candidate via Dynavax Takeout: Deals Report
#ACTRIMS26: Sanofi Unpacks Data From a Failed Phase 3 Tolebrutinib Trial in PPMS
Proxima Raises $80M in Seed Funding
Takeda Is ‘Not in Favor’ of Trump’s MFN Deals, CEO-Designate Says
Sanofi Plans Amlitelimab Dermatitis Filing After New Readout
Broadening T Cell Control in Atopic Dermatitis
Sanofi Suffers Another Sales Dip For 'Gift to Public Health' Vaccines
UK Body Raps Sanofi for Disparaging Pfizer's RSV Jab
Sanofi Appoints Specialty Care Head; Biogen Chair to Retire in June
QuantX Raises $85M Series B From Lilly, Sanofi Ventures
Novartis' Oral BTK Drug Moves the Needle in CINDU
U.S. Vaccine Approvals to Undergo Overhaul: What Do the Changes Mean?
Sanofi Announces the Signing of a Share Buyback Mandate for up to €1 Billion
Sanofi Linked to Takeover Bid for Ocular Therapeutix
Sanofi to Expand Hyderabad GCC; Plans Workforce Growth Beyond 4,500
Sanofi Says Its €15B Dealmaking Budget, R&D Spend Should Help Ease Looming Dupixent Patent Cliff
EMA Recommends Rezurock for Chronic Graft-Versus-Host Disease
Amgen Gives up on Its Once-Prized Eczema Drug
VantAI Gets $80M and New Name; Dynavax Discloses It Had Pre-Sanofi Suitor
Hepatotoxicity Headaches: One of the Hardest Risks to De-Risk
